[moc::"[[H&N]]"]
# Sinonasal
## local control modality
1. **Guntinas-Lichius 2007**  (surgery+PORT v surgery v RT)
 \*. DAHANCA 2020 guidelines (p35-6) 

## ENI
2. **Bristol 2007** (±ENI)

## SNUC
3. **MDACC Amit 2019** (iChemo response determines CCRT or Sx.)

## Esthesioneuroblastoma
4. **Ozsahin 2010** (predictors of outcome)

# Salivary
## PORT indications
1. **Terhaard 2005** (T3-4, close/+SM, bone invasion, PNI)
2. **Korea 2016** (omit for low-grade T1-2 with -SM)

## POCCRT v PORT
3. **NCDB Amini 2016** (PORT ± ChemoRT)
 \*. RTOG 1008 (ongoing: PORT ± Concurrent CisP)

## RT alone
4. **UF Mendenhall 2005** (RT worse than Surgery+PORT)

## Neutron
5. **RTOG 8001/MRC 1993** (improves LC ,not OS. Higher lTox)
6. **MSKCC Spratt 2014** (modern IMRT basically equivalent)


